scorecardresearch
Add as a preferred source on Google
Thursday, April 30, 2026
TopicDiabetes

Topic: Diabetes

Genes decide who responds better to GLP-1 drugs. How Nature study findings can change obesity treatment

The study finds specific genetic variants that predict how much weight a person will lose on taking weight loss drugs, & the severity of side effects they experience.

Why India’s national diabetes screening programme must include a 10-minute liver fibrosis test

Study involving over 9,000 patients, published in The Lancet, found that one in four adults with Type 2 diabetes had significant liver scarring and one in twenty had probable cirrhosis.

FSSAI has failed to resolve diet-related issues in India—public health crisis on the rise

The key question before us is simple: Whose interest should guide food policy in India? The credibility of India's food regulatory system depends on the answer to this question.

A 5-spice mix to fight long-term diabetes & obesity complications? ICMR set to back human trials

Looking beyond blood sugar control, ICMR-NIN scientists have combined 5 regular kitchen spices in precise proportions, 'marking a shift toward integrative health solutions'.

As GLP-1 generics flood Indian market, drug regulator cracks down on illegal sale & misleading ads

The push follows the patent expiry of semaglutide, which set off a rush of cheaper generics, but also exposed regulatory gaps—particularly in digital pharmacies and clinics.

Why US drugmaker Eli Lilly is warning against compounded tirzepatide mixed with vitamin B12

Tirzepatide is the active ingredient in Lilly’s popular anti-obesity & diabetes drugs, Mounjaro & Zepbound. Experts say the matter has little relevance for India at present.

Peak performance: Study finds red blood cells can reset diabetes maths in high altitude

A study published 19 February in Cell Metabolism, a Cell Press journal, found red blood cells step in as a major 'glucose sink' when oxygen levels fall.

South Asians eat better, yet have higher risk of diabetes, heart disease by 45. US study flags paradox

Researchers followed nearly 2,700 adults aged 45 to 55 over a decade, drawing data from two long-running cohort studies, find mismatch between healthier lifestyle and clinical risk.

Bitter pill for big pharma: Why Delhi HC upheld Centre’s ban on type 2 diabetes combination drug

Division bench of Delhi HC overturned 2019 order by single-judge bench, restoring ban on manufacture, sale, and distribution of triple-drug combinations for type 2 diabetes.

Is it too late? Researchers warn West Antarctic Ice Sheet at ‘extreme risk’ of collapse

Studies reveal Antarctic ice crisis, brainless robots powered by air, the power of ‘desert cherries’ in fighting diabetes, and the link between gut microbes and heart disease.

On Camera

New promo video by PLA Navy is a teaser of China’s deep blue capabilities

Rather than functioning as conventional propaganda, the video operates as a device for interpretation, subtly shaping expectations about future developments in China’s naval trajectory.

Adani’s giant copper plant hits technical setbacks in first year

The 500,000 tonne-per-year plant produced just 94,000 tonnes of refined copper from April 2025 to February this year.

Indian drone tech company ideaForge signs MoU with Japanese firm to develop next-gen AI powered drones

By pairing Indian drone engineering with Japanese semiconductor expertise, the two firms aim to develop more advanced autonomous systems tailored to both defence & commercial use.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.